ZNTL — ZENTALIS PHARMACEUTICALS INC
As of Q2 2026, 24 SEC-registered investment managers reported holding ZNTL (ZENTALIS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $84.28M across 17.42M shares. That is +19.3% by share count (+2.81M shares) versus the previous quarter, while reported value moved +146.6%. Ownership is concentrated: the five largest holders account for 69.1% of reported value and the top ten for 88.6%.
Compared with the prior quarter, 6 opened new positions, 12 added to existing stakes, 6 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ZNTL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Viking Global Investors history | Q2 2022 | 2.03M | $56.95M | 0.27% | Hold |
| BlackRock Inc history | Q2 2026 | 3.75M | $18.20M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 3.02M | $14.67M | 0.01% | Add |
| Capital World Investors history | Q3 2023 | 683.00K | $13.70M | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 2.34M | $11.34M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.61M | $7.80M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.28M | $6.23M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 1.11M | $5.41M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 2.86M | $3.86M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 664.28K | $3.22M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 591.47K | $2.87M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 546.57K | $2.65M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 471.25K | $2.29M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 388.30K | $1.88M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 372.56K | $1.81M | 0.00% | Reduce |
| Balyasny Asset Management history | Q3 2025 | 1.19M | $1.79M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 310.26K | $1.50M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 297.38K | $1.44M | 0.00% | Add |
| Baron Funds history | Q4 2021 | 12.00K | $1.01M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 171.91K | $833.77K | 0.00% | Add |
New Positions (Q2 2026)
- BNY Mellon 122.07K sh · $592.03K
- Deutsche Bank AG 48.81K sh · $236.71K
- JPMorgan Chase & Co 22.44K sh · $103.44K
- Manulife Financial 14.29K sh · $69.30K
- Legal & General Investment Management America 4.85K sh · $23.51K
- T. Rowe Price Associates 41.05K sh · $200
Fully Exited (vs previous quarter)
- Point72 Asset Management sold 94.85K sh · $221.96K
- AQR Capital Management sold 22.68K sh · $53.06K
- Prudential Financial sold 20.85K sh · $48.79K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 4.76M | 4.24M | 4.23M | 1.74M | 1.25M | 1.25M | 1.27M | 3.75M |
| Two Sigma Investments | 158.98K | 14.15K | 94.50K | — | — | — | — | 16.70K | 109.43K | — | 245.00K | 1.05M | 908.60K | 616.80K | 549.33K | 1.09M | 1.36M | 1.47M | 2.96M | 3.02M |
| Citadel Advisors | 1.12M | 620.04K | 533.92K | 782.79K | 604.00K | 663.82K | 1.34M | 2.14M | 2.18M | 3.74M | 3.88M | 4.54M | 2.79M | 3.23M | 90.56K | 484.34K | 2.11M | 1.96M | 1.76M | 2.34M |
| Renaissance Technologies | 31.34K | — | 109.34K | — | — | — | 32.74K | 210.44K | 285.44K | 309.28K | 261.94K | 661.68K | 556.94K | 539.35K | 826.04K | 1.53M | 2.33M | 2.88M | 1.94M | 1.61M |
| Geode Capital Management | 642.65K | 661.21K | 666.06K | 781.44K | 836.21K | 857.22K | 895.92K | 1.07M | 1.19M | 1.25M | 1.30M | 1.33M | 1.29M | 1.31M | 1.36M | 618.17K | 589.22K | 589.11K | 621.04K | 1.28M |
| Bank of America Corp | 84.35K | 197.39K | 284.25K | 309.47K | 122.14K | 240.34K | 300.29K | 265.48K | 232.96K | 718.64K | 475.96K | 508.23K | 775.54K | 216.00K | 1.13M | 713.32K | 1.55M | 1.37M | 1.13M | 1.11M |
| Millennium Management | — | 50.97K | 30.00K | — | 100.67K | 32.19K | 29.39K | 237.62K | 541.92K | 30.70K | 246.32K | 392.61K | 886.09K | 957.56K | 3.07M | 3.48M | 902.52K | 673.13K | 1.29M | 664.28K |
| Marshall Wace | — | — | — | — | — | — | — | 516.04K | 270.84K | 89.01K | 89.01K | 89.01K | 89.01K | 89.01K | — | — | — | 247.79K | 392.64K | 591.47K |
| D. E. Shaw & Co | 54.44K | 18.09K | 20.96K | 54.74K | 29.11K | — | — | — | 37.44K | — | 14.29K | 240.34K | 1.13M | 1.24M | 1.12M | 1.20M | 1.41M | 1.66M | 1.48M | 546.57K |
| Morgan Stanley | 48.23K | 30.14K | 177.84K | 345.74K | 97.39K | 133.46K | 271.26K | 502.88K | 545.62K | 609.48K | 1.04M | 1.95M | 1.61M | 1.71M | 1.09M | 1.10M | 1.41M | 803.65K | 350.21K | 471.25K |
| Northern Trust Corp | 348.33K | 349.76K | 339.23K | 373.90K | 417.04K | 420.04K | 426.87K | 478.80K | 540.72K | 530.00K | 523.70K | 495.27K | 474.23K | 484.74K | 462.30K | 123.44K | 94.12K | 92.87K | 118.19K | 388.30K |
| Goldman Sachs Group | 230.34K | 141.37K | 265.25K | 397.57K | 338.33K | 390.38K | 203.95K | 733.58K | 223.26K | 292.88K | 332.00K | 619.25K | 634.06K | 918.11K | 456.39K | 861.77K | 345.15K | 118.21K | 462.68K | 372.56K |
| Fidelity Management & Research (FMR) | 6.76M | 6.80M | 6.74M | 7.78M | 7.57M | 7.91M | 8.91M | 10.58M | 9.49M | 10.34M | 10.64M | 8.68M | 5.08M | 182.31K | 182.19K | 184.68K | 203.31K | 243.31K | 283.92K | 310.26K |
| UBS Group AG | 265 | 35.51K | 74.25K | 29.84K | 25.00K | 154.89K | 83.41K | 89.75K | 66.83K | 110 | 267.87K | 107.10K | 29.53K | 183.68K | 141.94K | 129.47K | 532.68K | 674.60K | 155.70K | 297.38K |
| Charles Schwab Investment Management | 252.55K | 261.01K | 267.84K | 320.54K | 323.50K | 335.76K | 333.57K | 405.85K | 442.06K | 445.82K | 455.94K | 468.41K | 406.21K | 497.36K | 486.50K | 299.10K | 41.98K | — | 51.09K | 171.91K |
| Invesco Ltd | 130.81K | 219.12K | 97.45K | 23.62K | 27.02K | 25.06K | 25.63K | 130.28K | 136.56K | 24.95K | 54.37K | 53.81K | 51.46K | 50.87K | 149.48K | 155.71K | 173.62K | 188.58K | 125.77K | 161.66K |
| BNY Mellon | 138.63K | 143.63K | 143.60K | 118.38K | 152.81K | 158.19K | 155.55K | 164.54K | 242.11K | 290.14K | 289.88K | 333.72K | 173.31K | 162.94K | 156.12K | — | — | — | — | 122.07K |
| Deutsche Bank AG | 33.80K | 34.99K | 33.15K | 22.53K | 68.65K | 37.40K | 44.82K | 419.23K | 32.08K | 42.91K | 30.82K | 23.75K | 31.93K | 42.80K | 42.80K | — | — | — | — | 48.81K |
| Wells Fargo & Co | 495.73K | 129.98K | 128.42K | 47.08K | 5.67K | 3.14K | 46.76K | 65.30K | 50.28K | 18.45K | 20.08K | 28.08K | 27.30K | 34.61K | 35.37K | 2.28K | — | — | 1 | 41.90K |
| Citigroup Inc | 33.83K | 61.66K | 31.44K | 130.85K | 168.81K | 101.93K | 188.72K | 85.41K | 85.20K | 145.92K | 257.09K | 43.93K | 43.69K | 45.50K | 40.65K | 19.45K | 906 | — | 77.25K | 23.11K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details